Preclinical Rational, Safety, and Preliminary Efficacy Results of Weekly Everolimus, Carboplatin and Paclitaxel as An Induction Therapy for Patients with Unresectable Locally Advanced Head & Neck Squamous Cell Carcinoma (CAPRA): A GERCOR-IRC Phase I/II Study

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 23; p. ix334
Main Authors Faivre, S., Dreyer, C., Raymond, E., Fayette, J., Delord, J.P., Gatineau, M., Chibaudel, B., Aissat, N., Slimane, K., Le Tourneau, C.
Format Journal Article
LanguageEnglish
Published 01.09.2012
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/S0923-7534(20)33581-X